<SEC-DOCUMENT>0001193125-21-355703.txt : 20211214
<SEC-HEADER>0001193125-21-355703.hdr.sgml : 20211214
<ACCEPTANCE-DATETIME>20211213190541
ACCESSION NUMBER:		0001193125-21-355703
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211213
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211214
DATE AS OF CHANGE:		20211213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Haymaker Acquisition Corp. III
		CENTRAL INDEX KEY:			0001819253
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40128
		FILM NUMBER:		211489287

	BUSINESS ADDRESS:	
		STREET 1:		650 FIFTH AVENUE FLOOR 10
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2126169600

	MAIL ADDRESS:	
		STREET 1:		650 FIFTH AVENUE FLOOR 10
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d266949d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hyac="http://haymaker.com/20211213" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-12-13_to_2021-12-13">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-12-13_to_2021-12-13">0001819253</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hyac-20211213.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-12-13_to_2021-12-13"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819253</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-12-13</xbrli:startDate> <xbrli:endDate>2021-12-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hyac:UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-12-13</xbrli:startDate> <xbrli:endDate>2021-12-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-12-13</xbrli:startDate> <xbrli:endDate>2021-12-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hyac:WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-12-13</xbrli:startDate> <xbrli:endDate>2021-12-13</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-12-13_to_2021-12-13">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt:datemonthdayyearen">December 13, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-12-13_to_2021-12-13">Haymaker Acquisition Corp. III</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-12-13_to_2021-12-13">001-40128</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-12-13_to_2021-12-13">85-1791125</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-12-13_to_2021-12-13">501 Madison Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-12-13_to_2021-12-13">Floor 12</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-12-13_to_2021-12-13">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-12-13_to_2021-12-13">NY</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-12-13_to_2021-12-13">10022</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-12-13_to_2021-12-13">(212)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-12-13_to_2021-12-13">616-9600</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">HYACU</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">Class A common stock, par value $0.0001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">HYAC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">HYACW</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2021-12-13_to_2021-12-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;7.01 Regulation FD Disclosure. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, Haymaker Acquisition Corp. III, a Delaware corporation (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;), entered into a Business Combination Agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Business Combination Agreement</span></span>&#8221;) with Haymaker Sponsor III LLC, a Delaware limited liability company, BioTe Holdings, LLC, a Nevada limited liability company (&#8220;<span style="font-weight:bold"><span style="font-style:italic">BioTE</span></span>&#8221;), BioTe Management, LLC, a Nevada limited liability company, Dr.&#160;Gary Donovitz, in his individual capacity, and Teresa S. Weber, in her capacity as the members&#8217; representative. The transactions contemplated by the Business Combination Agreement are referred to herein as the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Business Combination</span></span>.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;13, 2021, members of management of the Company and BioTE released a joint webcast in connection with the announcement of their entry into the Business Combination Agreement. A copy of the investor presentation that was referenced during the webcast was previously filed by the Company on December&#160;13, 2021 on a Current Report on Form <span style="white-space:nowrap">8-K.</span> The transcript of the joint webcast is furnished hereto as Exhibit 99.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Exchange Act</span></span>&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1993, as amended (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Securities Act</span></span>&#8221;), or the Exchange Act, except as expressly set forth by specific reference in such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Important Information About the Business Combination and Where to Find It </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> relates to a Business Combination between the Company and BioTE. A full description of the terms of the Business Combination will be provided in a proxy statement to be filed with the U.S. Securities and Exchange Commission (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">SEC</span></span>&#8221;) by the Company, which will be mailed to its stockholders once definitive. This Current Report on Form <span style="white-space:nowrap">8-K</span> does not contain all the information that should be considered concerning the Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the Business Combination. The Company&#8217;s stockholders and other interested persons are advised to read, when available, the preliminary proxy statement and the amendments thereto and the definitive proxy statement and other documents filed in connection with the Business Combination, as these materials will contain important information about BioTE, the Company and the Business Combination. When available, the definitive proxy statement and other relevant materials for the Business Combination will be mailed to stockholders of the Company as of a record date to be established for voting on the Business Combination. Stockholders of the Company will also be able to obtain copies of the preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC, without charge, once available, at the SEC&#8217;s website at www.sec.gov, or by directing a written request to: Haymaker, 501 Madison Avenue, 12th Floor, New York, NY 10022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Participants in the Solicitation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company and its directors and executive officers may be deemed participants in the solicitation of proxies from the Company&#8217;s stockholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in the Company is contained in the Company&#8217;s registration statement on Form <span style="white-space:nowrap">S-1,</span> which was filed with the SEC and is available free of charge at the SEC&#8217;s web site at www.sec.gov, or by directing a written request to the Company, 501 Madison Avenue, 12th Floor, New York, NY 10022. Additional information regarding the interests of such participants will be contained in the proxy statement for the Business Combination when available. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BioTE and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of the Company in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be included in the proxy statement for the Business Combination when available. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains certain &#8220;forward-looking statements&#8221; within the meaning of the federal U.S. securities laws with respect to the Business Combination between the Company and BioTE, the benefits of the transaction, the amount of cash the transaction will provide BioTE, the anticipated timing of the transaction, the services and markets of BioTE, the Company&#8217;s expectations regarding future growth, results of operations, performance, future capital and other expenditures, competitive advantages, business prospects and opportunities, future plans and intentions, results, level of activities, performance, goals or achievements or other future events. These forward-looking statements generally are identified by words such as &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;may&#8221;, &#8220;could&#8221;, &#8220;will&#8221;, &#8220;potential&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;should&#8221;, &#8220;plan&#8221;, &#8220;predict&#8221;, or the negative or other variations of such statements, reflect the Company&#8217;s management&#8217;s current beliefs and assumptions and are based on the information currently available to the Company&#8217;s management. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: (i)&#160;the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of the Company&#8217;s </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities; (ii)&#160;the risk that the transaction may not be completed by the Company&#8217;s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by the Company; (iii)&#160;the failure to satisfy the conditions to the consummation of the transaction, including the approval of the Business Combination Agreement by the stockholders of the Company, the satisfaction of the minimum cash amount following any redemptions by the Company&#8217;s public stockholders and the receipt of certain governmental and regulatory approvals; (iv)&#160;the lack of a third-party valuation in determining whether or not to pursue the proposed transaction; (v)&#160;the occurrence of any event, change or other circumstance that could give rise to the termination of the Business Combination Agreement; (vi)&#160;the effect of the announcement or pendency of the transaction on BioTE&#8217;s business relationships, operating results and business generally; (vii)&#160;risks that the proposed transaction disrupts current plans and operations of BioTE; (viii)&#160;the outcome of any legal proceedings that may be instituted against BioTE or the Company related to the Business Combination Agreement or the proposed transaction; (ix)&#160;the ability to maintain the listing of the Company&#8217;s securities on a national securities exchange; (x)&#160;changes in the competitive industries in which BioTE operates, variations in operating performance across competitors, changes in laws and regulations affecting BioTE&#8217;s business and changes in the combined capital structure; (xi)&#160;the ability to implement business plans, forecasts and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities; (xii)&#160;the risk of downturns in the market and BioTE&#8217;s industry including, but not limited to, as a result of the <span style="white-space:nowrap">COVID-19</span> pandemic; (xiii)&#160;costs related to the transaction and the failure to realize anticipated benefits of the transaction or to realize estimated pro forma results and underlying assumptions, including with respect to estimated stockholder redemptions; (xiv)&#160;the inability to complete the Truist debt financing; and (xv)&#160;risks and uncertainties related to BioTE&#8217;s business, including, but not limited to, those related to regulation, its supply chain, its executive influence, its limited operating history, highly competitive markets and competition, data privacy and cybersecurity, its ability to grow, its financial condition and potential dilution, its forecasts, expansion, intellectual property, current or future litigation, capital requirements and the need for additional capital, physician training, relationships with physicians, its key employees and qualified personnel, third-party manufacturers, regulatory scrutiny of the pharmacy compounding industry, health care fraud and abuse, HIPAA, and its nutraceutical business. The foregoing list of factors is not exclusive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &#8220;Risk Factors&#8221; section of proxy statement, when available, and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and neither BioTE nor the Company assume any obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Neither the Company nor BioTE gives any assurance that either the Company or BioTE, or the combined company, will achieve its expectations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Non-Solicitation</span> </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination or any other matter and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of the Company, BioTE or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01. Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td style="width:90%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d266949dex991.htm">Transcript for Webcast, dated December&#160;13, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data file (embedded within the inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">HAYMAKER ACQUISITION CORP. III</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Bradley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; font-size:10pt; font-family:Times New Roman">Christopher Bradley</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</p></td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December&#160;13, 2021 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d266949dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Andy Heyer: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Welcome to the Biote corporate presentation.
This is Andy Heyer from Haymaker III, and we&#146;re excited you can join us. Biote is a really dynamic consumer healthcare company, and we&#146;re really looking forward to telling you about it. The key players are shown here. As many of you know,
my brother and I have formed Haymaker one and two in the past and successfully completed acquisitions. In the case of Haymaker I with OneSpaWorld, ticker symbol &#147;OSW&#148;, and with ARKO for Haymaker II, ticker symbol &#147;ARKO,&#148; our
backgrounds as indicated here, while seemingly different, are actually very similar, and we believe is why we&#146;ve been a successful SPAC team. My background was in banking, leading into private equity with a specialty in consumer-facing
businesses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">My brother&#146;s background, as you can see from those logos, was first at Booz Allen Hamilton, where he created the consumer practice and
ran the New York office. But ultimately, he ran four major public companies: Young&nbsp;&amp; Rubicam, Turner Broadcasting, the Coca-Cola Company, where he was president, and Starwood Hotels, where he was CEO. We have found ourselves to be well
received by targets for SPACs because we believe we can add a lot of value to the companies we partner with, and that&#146;s certainly the case, we believe, with Biote, and let me just hand it over to Terry Weber at this point. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terry Weber: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hello, I&#146;m Terry Weber, the CEO of
Biote. I&#146;ve been a disruptor and an innovator at companies across a wide array of industries, including many consumer brands. I&#146;m an operator, experienced at scaling businesses by growing their geographic profile. I&#146;ve brought these
skills to Biote as we continue our accelerated growth. Also, I would like to talk about Dr.&nbsp;Jonathan Sackner Bernstein, who is Biote&#146;s Chief Medical Officer. A cardiologist by training, Jonathan served on the faculty of Columbia
University. His experience spans medical product development, including drugs, biologics and medical devices. With his experience in senior positions at the FDA, Jonathan brings regulatory and clinical leadership to Biote. We&#146;re also joined by
Marc Beer, Chairman of Biote. Mark brings more than 25 years of development and commercialization experience from across the healthcare sectors. He&#146;s a serial entrepreneur with a track record of successfully growing public healthcare companies.
Marc&#146;s experience will be an invaluable asset as Biote continues its geographic expansion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Andy Heyer: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So turning to the next slide, we always like to tell our investors, sort of report on ourselves, and give ourselves a report card compared to what we indicated
Haymaker III would be looking for, and Biote checks all the boxes, as you can see. The company is a market leader in health and wellness with obviously strong momentum behind those sectors. There are certain characteristics, in particular though,
that we look for in all of our transactions and which we have promised to SPAC investors, which is a consumer-facing business with a strong demographic push. It has to have demonstrable growth. We love recurring revenue businesses, which Biote is.
We love asset-light businesses with huge free cash flow conversion, and obviously we want a strong management team, but we also are very focused on situations where we believe our team adds value. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not short term holders. In both the case of OneSpaWorld and ARKO, we have never sold a share of either company because we invested in the long-term
story, and we believe Biote has a very long-term story, both of near-term growth and huge legs for a long-term build. We also think we can add value to this company through branding and marketing direct to consumers, which they haven&#146;t done in
the past. Before I turn it back to Terry, let me just show you some of the numbers because they really do speak for themselves. Biote has all the characteristics necessary to be a great stock, which is obviously the key to any successful SPAC
transaction. The company&#146;s a market leader with a huge addressable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 1 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
market and tremendous underdeveloped white space. We&#146;re eleven times larger than our nearest competitor. It&#146;s a patient-driven and physician-directed consumer businesses, which is
something we know a lot about. But most importantly, there are high retention rates, recurring revenue, which makes the revenue model extremely predictable. The EBITDA margins are strong and as we&#146;ll discuss later, we believe it&#146;s been
priced very attractively for investors. Terry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terry Weber: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you. Now I&#146;d like to talk to you about how Biote is transforming healthy aging. Since 2012, Biote&#146;s been innovating in the hormone optimization
therapy market. We&#146;re a high growth, high profit company, and I&#146;m proud to say in 2020, even a difficult COVID year, we had revenues of $116&nbsp;million and an EBITDA of $33&nbsp;million, and we&#146;re growing rapidly. We&#146;ve got a
CAGR of 21% on revenue in the last five years. We&#146;ve built this commercial operating expertise with over 4,700 providers in 2,800 clinics representing less than 2% of the addressable market. Our treatment platform is proprietary and there are
high barriers to entry in this market, making it difficult for competitors to gain a toehold. As Andy said, we&#146;re eleven times larger than the closest competitor in a highly fragmented market. We have great retention rate for our providers,
which is 90%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regardless of how careful we are with our preventative care, after the age of 40, many of us experience a variety of symptoms or live with
somebody who does. What do all these symptoms listed on the left have in common? They&#146;re all linked to hormone deficiency. Hormone deficiency is a medical condition like hypertension or diabetes, and it can affect one&#146;s general health and
absolutely the quality of life. On the right-hand side, you see that research has shown hormone deficiency has also been linked to diseases such as heart disease, breast cancer and osteoporosis. And here we show, according to a study published in
the American Journal of Obstetrics and Gynecology, hormone optimization, like Biote does, improves a wide variety of symptoms. So let&#146;s take hot flashes and night sweats for example. As you can see from this chart, 81% of patients in menopause
experience hot flashes and night sweats. After hormone optimization, as you see in the center column, 90% of those same patients experience relief from hot flashes and night sweats. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patients see similar levels of relief from other symptoms such as insomnia, depression, lethargy and more. Now let&#146;s look at the size of the target
patient population for Biote. Approximately 200&nbsp;million Americans are affected by hormone imbalance. Women experience a 67% reduction in estradiol between the <FONT STYLE="white-space:nowrap">mid-forties</FONT> and <FONT
STYLE="white-space:nowrap">mid-fifties.</FONT> Over 47&nbsp;million women in the US are affected by menopausal symptoms, yet only 28% undergo treatment. Men, on the other hand, experience a 44% reduction in testosterone between the ages of 30 and
74. This condition affects 40% of men over 45, yet only 10 to 12% are receiving testosterone therapy. And if you look at the right hand side of the slide, it shows you that our core business, hormone therapy, represents a $7&nbsp;billion domestic
market. There&#146;s ample opportunity for growth with a forecasted CAGR of 7% in the next five years. This is a growing market that has barely touched a highly-underserved population. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">And when considering options for hormone replacement, the Biote method is well positioned to become a mainstream therapy, primarily because, number one, the
protocols are administered by a Biote certified medical practitioner, we use personalized dosing, and they deliver a sustained release product resulting in strong patient acceptance and compliance. If you look at the left hand side of the slide,
you&#146;ll see the size of the pellet practitioners use. It&#146;s about the size of a grain of rice. These small bioidentical pellets are placed subcutaneously in the backside or flank of a patient. And on the right hand side, you see several
hormone therapy options that are often cumbersome and time consuming, whether it&#146;s a prescription cream, a patch, pills or injectables, and I want you to appreciate that if patients do not use a sustained release product like pellets,
they&#146;ll need to take one to three pills per day, or injections biweekly or weekly instead of the two to three procedures per year with the Biote method. We offer a high-quality hormone therapy administered in a bioidentical form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 2 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our proprietary BioTracker systems give guidance to our practitioners that they&#146;re dosing their
patients correctly. We also offer differentiated nutraceuticals and cosmeceuticals that complement our protocols. Currently, 82% of our business is in hormone therapy. Now I&#146;d like to talk about our operating experience. In the last several
years, we&#146;ve built up the infrastructure to support the growth of sales. Currently our sales team has over 80 highly trained and experienced support staff that are placed throughout the US, and we will expand that department 50% in the next 12
months. Our marketing team uses state of the art technology to target and engage the practitioners and patients where they want to be met. We have built a world class <FONT STYLE="white-space:nowrap">in-house</FONT> agency that delivers data driven,
omnichannel communication strategies. We operate a large national training center in Dallas, where we train over 250 practitioners at a time, and five regional training centers. We employ 17 clinical staff and 69 experienced mentors who continue
ongoing training and evaluation of our providers in the field. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our customer support and call center are the fastest growing groups in the company,
gearing up for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">direct-to-consumer</FONT></FONT> and telemedicine. At Biote, we&#146;re committed to quality research. We&#146;re making a significant investment to validate our
protocols and advance the science. We recently published our nine-year breast cancer study and a safety study, both in peer-reviewed journals. In summary on the safety study, we showed a complication rate of less than 1%. Let&#146;s take a look at
the snapshot of our robust financial performance. As you can see, we have a track record of five years of growth. Biote is well positioned for future growth and profitability, with rising cash flow and expanding sales growth. The first three
quarters of 2021 have been very strong and we&#146;re on track to finish a great year. We&#146;re also forecasting strong growth in the next two years. We&#146;re projecting accelerated growth in both revenue and EBITDA in 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business model is highly capital efficient and prime for exponential scale. I&#146;ve reviewed with you the size of the current market and the TAM of
200&nbsp;million Americans with these symptoms with 80% untreated. There is ample opportunity for category growth with a CAGR of 7% forecasted in the next five years. On the right, you can see our Biote certified practitioners have over 300,000
active patients. This large database of patients allows us to extrapolate a clear demographic picture of the existing patients and the addressable market. If you look at the bottom sphere, it&#146;s an interesting note that 50% of the patient base
makes less than $100,000 in household income annually. Ours is a private pay therapy that nearly everyone can afford. It costs approximately $4 per day for women and $4.50 a day for men, less than a cup of coffee. The vast majority of our patients,
both male and female, are between the ages of 45 and 64, which again supports our robust market opportunity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we look at the proprietary Biote model,
look to the left. It begins with brand awareness and an introduction to Biote from a referral or a lead jet. We provide industry leading didactic and <FONT STYLE="white-space:nowrap">in-clinic</FONT> certification training where the practitioners
pay to attend our training and on testing and completion, receive certification. We provide clinical mentors throughout the country and a 24/7 therapy line for assistance, creating a safety net for our practitioners. We provide high quality hormone
pellets as part of a complete <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> therapeutic platform. We feel very good about our competitive moat for a variety of reasons. First, Biote has a proprietary
tracking system that keeps our practitioners and their offices up to date on state and federal compliance. Second, we&#146;ve developed proprietary operating models based on 30 years of patient experience, updated regularly based on our ongoing
research. And third, and finally, the critical step of training our practitioners and their staff in the very best clinical practices and patient marketing. All of this results in greater practice and patient retention. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 3 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is our proprietary business model that set us apart from the competition, with the closest competitors
having only a fraction of the provider market. There have been many others chasing Biote for over nine years, and they have struggled to compete. If you look at the top graph, you&#146;ll see the extraordinary growth in the number of certified
clinics we&#146;ve added in the last four years. Let&#146;s look at the physician economics, the value that we bring to the providers. At Biote, we created a business model that delivers provider economics in a material manner. Our business model
offers a profitable therapy to the practice from day one after they leave training. As you can see, our average clinic is making $100,000 in profit annually, and our top 100 clinics are approaching $500,000 in profit each year. We help them get
there, and we help them stay there. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biote drives our revenues by contractually sharing in that profit generated from each procedure performed by the
practitioners. Let me break down the potential provider market. We currently have over 4,700 practitioners in 2,800 clinics. We view the target practitioners as family practice, OBGYN, internal medicine and urology, and there&#146;s over 260,000 of
those specialists in the US alone. We also have additional providers treating our patients who are nurse practitioners and other specialties like cardiology, and that increases this universe to 1.2&nbsp;million potential providers in the US.
It&#146;s a very big market and the real growth opportunity is in front of us. Now, let me tell you how we&#146;re going to reach that potential. We primarily operate in 10 core states that collectively generate approximately 70% of our revenue, and
we&#146;re not even saturated in those states. There&#146;s still room to grow in our core geography. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">And as we look to the future and a much larger
opportunity, we&#146;re expanding in the remaining states, partnering with targeted practitioner groups, from family medicine, physicians to urologists. We have 200 successful practices in Puerto Rico also, and plan to focus on international
expansion in the first half of 2023. As you can see, we have a solid base of providers and patients in a core number of states, but we&#146;re just beginning to scratch the surface. The majority of our growth is still ahead of us. The geographic
scalability of our Biote business is both predictable and capital efficient. Biote has the blueprint to achieve accelerated growth in the years to come through a class of scale of commercial operation to a well-targeted provider group. As you can
see here, our revenue and EBITDA growth have been impressive in the past and our margin has remained strong, and if I can focus you on the orange columns in these charts, they detail strong projected growth as well. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With our unique and predictable commercial scale model, we&#146;re forecasting accelerated growth in both revenue and EBITDA going forward. This performance
and the solidity of our business cannot take place without a great operating team. I&#146;ve assembled a group of highly experienced professionals who scaled businesses both in healthcare and consumer. We&#146;re also supported by an exceptional
clinical and scientific research group. My team is entrepreneurial, committed to the mission and to the continued growth of this company. I&#146;m very fortunate to be working with each and every one of them and also with the Haymaker group. Now
I&#146;ll pass it back to Andy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Andy Heyer: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thanks,
Terry. If you all turn to the transaction overview, you&#146;ll see that we have $318&nbsp;million in the SPAC trust. The transaction contemplates a very substantial equity rollover, minimal debt and substantial cash on the balance sheet. We believe
these are all the right metrics to have a high growth, well-funded and safe company. Let me touch on valuation here for a second, but I&#146;m going to spend a little more time on that in a minute. As you can see at the bottom, at the $10 stated
SPAC price, the multiple of sales and of &#145;22 EBITDA are approximately four times on sales and between 13 and 14.5 times on EBITDA, based on our projections for next year. We believe this is an extraordinarily reasonable pricing, and we&#146;ll
demonstrate to you that there is a clear path to a <FONT STYLE="white-space:nowrap">mid-teens</FONT> stock price, in our opinion. As a company that is 11 times larger than its nearest competitor, there&#146;s obviously no obvious direct comp. We
have focused on consumer facing wellness companies that are category leading as well as disruptive within that category. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 4 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the next few pages, you will see metrics on companies that have various characteristics similar to Biote,
whether their business model or their financial statistics. We believe that Biote is most similar to Align and HydraFacial, HydraFacial being a very successful SPAC transaction completed earlier this year. These are consumer-driven businesses with
similar financial statistics and growth characteristics. In particular, if you look at the first slide, you&#146;ll see that the Biote sales CAGR is very similar to that of Align. Similarly, the EBITDA CAGR is actually higher for Biote than for
Align. On the next page, the EBITDA margin is virtually identical to Align and the free cash flow conversion at 93.8 is truly exceptional and is better than both Align and AirSculpt, the company that recently went public. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">But going to the last page, the last page really tells the story because in order to get this company successfully launched and to give upside to investors,
both the inside investors and potential new public investors, you can see that we&#146;ve priced the transaction at a modest 4 times sales compared to Align at 10.2, and at 13.3 to 14.5 times EBITDA compared to 33 times on Align. So, we&#146;re
hoping you&#146;re as excited about Biote as we are. It is rare to have an opportunity to invest in a company that is so dominant within its space with such fabulous financial statistics. So thank you very much for listening and we look forward to
talking to you in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information About the Proposed Business Combination and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This transcript relates to a proposed business combination between Haymaker Acquisition Corp. III (&#147;Haymaker&#148;) and Biote Holdings, LLC
(&#147;Biote&#148;). A full description of the terms of the business combination will be provided in a proxy statement to be filed with the United States Securities and Exchange Commission (the &#147;SEC&#148;) by Haymaker, which will be mailed to
its stockholders once definitive. This transcript does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in
respect of the proposed business combination. Haymaker&#146;s stockholders and other interested persons are advised to read, when available, the preliminary proxy statement and the amendments thereto and the definitive proxy statement and other
documents filed in connection with the proposed business combination, as these materials will contain important information about Biote, Haymaker and the proposed business combination. When available, the definitive proxy statement and other
relevant materials for the proposed business combination will be mailed to stockholders of Haymaker as of a record date to be established for voting on the proposed business combination. Stockholders of Haymaker will also be able to obtain copies of
the preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC, without charge, once available, at the SEC&#146;s website at www.sec.gov, or by directing a written request to: Haymaker, 501 Madison Avenue,
12th Floor, New York, NY 10022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the Solicitation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Haymaker and its directors and executive officers may be deemed participants in the solicitation of proxies from Haymaker&#146;s stockholders with respect to
the proposed business combination. A list of the names of those directors and executive officers and a description of their interests in Haymaker is contained in Haymaker&#146;s registration statement on Form
<FONT STYLE="white-space:nowrap">S-1,</FONT> which was filed with the SEC and is available free of charge at the SEC&#146;s web site at www.sec.gov, or by directing a written request to Haymaker, 501 Madison Avenue, 12th Floor, New York, NY 10022.
Additional information regarding the interests of such participants will be contained in the proxy statement for the proposed business combination when available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 5 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biote and its directors and executive officers may also be deemed to be participants in the solicitation of
proxies from the stockholders of Haymaker in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be
included in the proxy statement for the proposed business combination when available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for historical information contained herein, this transcript contains certain &#147;forward-looking statements&#148; within the meaning of the federal
U.S. securities laws with respect to the proposed business combination between Haymaker and Biote, the benefits of the transaction, the amount of cash the transaction will provide Biote, the anticipated timing of the transaction, the services and
markets of Biote, our expectations regarding future growth, results of operations, performance, future capital and other expenditures, competitive advantages, business prospects and opportunities, future plans and intentions, results, level of
activities, performance, goals or achievements or other future events. These forward-looking statements generally are identified by words such as &#147;anticipate&#148;, &#147;believe&#148;, &#147;expect&#148;, &#147;may&#148;, &#147;could&#148;,
&#147;will&#148;, &#147;potential&#148;, &#147;intend&#148;, &#147;estimate&#148;, &#147;should&#148;, &#147;plan&#148;, &#147;predict&#148;, or the negative or other variations of such statements, reflect our management&#146;s current beliefs and
assumptions and are based on the information currently available to our management. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: (i)&nbsp;the risk that the
transaction may not be completed in a timely manner or at all, which may adversely affect the price of Haymaker&#146;s securities; (ii)&nbsp;the risk that the transaction may not be completed by Haymaker&#146;s business combination deadline and the
potential failure to obtain an extension of the business combination deadline if sought by Haymaker; (iii)&nbsp;the failure to satisfy the conditions to the consummation of the transaction, including the approval of the business combination
agreement by the stockholders of Haymaker, the satisfaction of the minimum cash amount following any redemptions by Haymaker&#146;s public stockholders and the receipt of certain governmental and regulatory approvals; (iv)&nbsp;the lack of a
third-party valuation in determining whether or not to pursue the proposed transaction; (v)&nbsp;the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; (vi)&nbsp;the
effect of the announcement or pendency of the transaction on Biote&#146;s business relationships, operating results and business generally; (vii)&nbsp;risks that the proposed transaction disrupts current plans and operations of Biote;
(viii)&nbsp;the outcome of any legal proceedings that may be instituted against Biote or Haymaker related to the business combination agreement or the proposed transaction; (ix)&nbsp;the ability to maintain the listing of Haymaker&#146;s securities
on a national securities exchange; (x)&nbsp;changes in the competitive industries in which Biote operates, variations in operating performance across competitors, changes in laws and regulations affecting Biote&#146;s business and changes in the
combined capital structure; (xi)&nbsp;the ability to implement business plans, forecasts and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities; (xii)&nbsp;the risk of downturns in
the market and Biote&#146;s industry including, but not limited to, as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; (xiii)&nbsp;costs related to the transaction and the failure to realize anticipated benefits of the
transaction or to realize estimated pro forma results and underlying assumptions, including with respect to estimated stockholder redemptions; (xiv)&nbsp;the inability to complete the Truist debt financing; and (xv)&nbsp;risks and uncertainties
related to Biote&#146;s business, including, but not limited to, those related to regulation, its supply chain, its executive influence, its limited operating history, highly competitive markets and competition, data privacy and cybersecurity, its
ability </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 6 of 7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to grow, its financial condition and potential dilution, its forecasts, expansion, intellectual property, current or future litigation, capital requirements and the need for additional capital,
physician training, relationships with physicians, its key employees and qualified personnel, third-party manufacturers, regulatory scrutiny of the pharmacy compounding industry, health care fraud and abuse, HIPAA, and its nutraceutical business.
The foregoing list of factors is not exclusive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &#147;Risk Factors&#148; section of proxy statement, when available, and other documents filed
by Haymaker from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Forward-looking statements speak only as of the date on which they are made, and neither Biote nor Haymaker assume any obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new
information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Neither Haymaker nor Biote gives any assurance that either Haymaker or Biote, or the combined company, will achieve its
expectations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This transcript is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential
business combination or any other matter and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Haymaker, Biote or the combined company, nor shall there be any sale of any such securities in any state or
jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting
the requirements of the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This transcript includes certain financial measures not presented in accordance with generally accepted accounting principles in the United States
(&#147;GAAP&#148;), including Adjusted EBITDA (including on a forward-looking basis). These financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and
assessing our financial results. Therefore, these measures should not be considered in isolation or as an alternative to net loss or other measures of profitability, liquidity or performance under GAAP. You should be aware that Biote&#146;s
presentation of these measures may not be comparable to similarly titled measures used by other companies, which may be defined and calculated differently. Biote believes that these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures of
financial results (including on a forward-looking basis) provide useful supplemental information to investors about Biote. Biote management uses forward-looking <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures to evaluate Biote&#146;s
projected financials and operating performance. Additionally, to the extent that forward-looking <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures are provided, they are presented on a
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> basis without reconciliations of such forward-looking <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures due to the inherent difficulty in forecasting and quantifying certain amounts that are
necessary for such reconciliations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Page 7 of 7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hyac-20211213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 12/14/2021 5:01:52 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:hyac="http://haymaker.com/20211213"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"

  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://haymaker.com/20211213"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />

    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hyac-20211213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hyac-20211213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hyac-20211213_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="hyac_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hyac_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" name="WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>hyac-20211213_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 12/14/2021 5:01:55 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hyac-20211213.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" xlink:type="locator" xlink:label="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" xlink:type="locator" xlink:label="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="hyac_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hyac_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="54.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hyac-20211213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 12/14/2021 5:01:52 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hyac_DocumentAndEntityInformationTable" xlink:to="hyac_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="hyac_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="hyac_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="hyac_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="hyac_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="hyac_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="hyac-20211213.xsd#hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" xlink:type="locator" xlink:label="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" xlink:to="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Units Each Consisting Of One Share Of Class A Common Stock And One Fourth Of One Redeemable Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Units Each Consisting Of One Share Of Class A Common Stock And One Fourth Of One Redeemable Warrant [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Class A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Class A [Member]</link:label>
    <link:loc xlink:href="hyac-20211213.xsd#hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" xlink:type="locator" xlink:label="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" xlink:to="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock For 11.50 Per Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock For 11.50 Per Share [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hyac-20211213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 12/14/2021 5:01:53 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hyac-20211213.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="hyac_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hyac_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationTable" xlink:to="hyac_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" xlink:type="locator" xlink:label="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hyac-20211213.xsd#hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" xlink:type="locator" xlink:label="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hyac_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="54.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d266949d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:hyac="http://haymaker.com/20211213"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hyac-20211213.xsd" xlink:type="simple"/>
    <context id="duration_2021-12-13_to_2021-12-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819253</identifier>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hyac:UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hyac:WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-12-13_to_2021-12-13">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-12-13_to_2021-12-13"
      id="Hidden_dei_EntityCentralIndexKey">0001819253</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-12-13_to_2021-12-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-12-13_to_2021-12-13">2021-12-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-12-13_to_2021-12-13">Haymaker Acquisition Corp. III</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-12-13_to_2021-12-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-12-13_to_2021-12-13">001-40128</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-12-13_to_2021-12-13">85-1791125</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-12-13_to_2021-12-13">501 Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-12-13_to_2021-12-13">Floor 12</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-12-13_to_2021-12-13">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-12-13_to_2021-12-13">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-12-13_to_2021-12-13">10022</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-12-13_to_2021-12-13">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-12-13_to_2021-12-13">616-9600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-12-13_to_2021-12-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-12-13_to_2021-12-13">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-12-13_to_2021-12-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-12-13_to_2021-12-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">HYACU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">Class A common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">HYAC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">HYACW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-12-13_to_2021-12-13_us-gaap-StatementClassOfStockAxis_hyac-WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-12-13_to_2021-12-13">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2021-12-13_to_2021-12-13">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140072749514552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hyac_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001819253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 13,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Haymaker Acquisition Corp. III<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-1791125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">501 Madison Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Floor 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">616-9600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember', window );">Units Each Consisting Of One Share Of Class A Common Stock And One Fourth Of One Redeemable Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hyac_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HYACU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hyac_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class A common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HYAC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember', window );">Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock For 11.50 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hyac_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HYACW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hyac_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hyac_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hyac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "TF(U3+1Q*=X@%  #/&   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+V946_;-A#'G[M/01A]V( D%JDX<8HD@.LXB]$V]>)T05?L@99H6X@DNB0=
M.]]^1TH1O4X^"6O1E\:RR3]_/)[^=U+/-U(]ZJ40AFRS--<7G:4QJS?=KHZ6
M(N/Z2*Y$#K_,I<JX@4NUZ.J5$CQVD[*TRX+@I)OQ).]<GKOO)NKR7*Y-FN1B
MHHA>9QE7SV]%*C<7'=IY^>(N62R-_:)[>;[B"S$5YM-JHN"J6ZG$229RG<B<
M*#&_Z SHF[=AWTYP(_Y,Q$;O?"9V*S,I'^W%.+[H!)9(I"(R5H+#GR<Q%&EJ
ME8#C:RG:J=:T$W<_OZA?N\W#9F9<BZ%,'Y+8+"\Z_0Z)Q9RO4W,G-S>BW%#/
MZD4RU>Y?LBG'!AT2K;6163D9"+(D+_[R;1F(-A-8.8$Y[F(A1WG%#;\\5W)#
ME!T-:O:#VZJ;#7!);D]E:A3\FL \<WDEHS4$V1">QV24F\0\DW%>G#9$[;QK
M8!$[M!N5@F\+0;9/4$1'A(8'A 6,_GMZ%]@J0%8!,J<7-@$.:@')E_<P@8R-
MR/3?R')AM5SHECO>L]P UHK=>M<I7]1M'Y\_YZD6",=QQ7&,ZI0['0*)XBGL
M.!9;\DX\UQ'A2D$0T#X]8[T0P>I56#U4K#J-^^>5J&/!I_</WR$0)Q7$23N(
MB5")M%D1$TC^6IX&I3)9?WGUJB%=3RNVTS;G=B<6B8:3 \A;GM62X3HW_#GC
MCT*10?1UG>C$Y?I0JM41&8_'"&B_ NVW 1WG$8A*5=Q,4P-AA&76D'60?#*N
M)<>%KT8(W5E%=]:&[CI)!;E=9S.AZD!P#<C[P^. LC["0P/ODT$;HGN^)>,8
MDB^9)U$1M/U\#9+]WB$]/:.4]3#"'2>G;0@'<:R$U@<O'X@SR(]Y[5$V2/8"
M2C[P.-&PS<&3R->8M5%OZ93]?]+[C:PEQ26O4RD5H0SC\S6 XB;^+=_07H'\
MO=S45T1<[A9ZD\_0FV!LOB[05H6A8BMN68";*/F4Y%'],>.:MY\Q-%\;*.[N
MWZ)-I#90N_Y*5GNMI$&1!@%#C]27#(H[O3O" ?2M^U%P@5\99;]A*+Y"4-S:
MW\L(HC)9RASSM@:1$WIR>'82!!B1+P44M^P'E1@C;'W)LG5>^IJNI<*%FKH?
MZOV?XN8]E6D20=7+%V! !NH\3VMY<!6C4,=BWOT9;M43)5QT!-Q@1?\#;2)4
MYX_S>?WQ->@U!8IYUV>X1?^';*SU&L@: 7'91L"=_KV5V8\RH1;V.'\'!;.T
MS"N>U_:S#8)-A^IMGK6R^=&6W$.G5O9814]9B_5]G3_S%L]P._Z4)T:3$8]L
ME(!+N]O@X]P6<3)=<CAQN!BF'$KFP!V^:]UD].@>DNRH:[E6$.1RSIV(!3S,
MSZ"9>N#*=:5?/@CK/-@C$_/&SWH_XQF->3=GN!E/1;16=A7*9N0^,6FMHS>(
MN# ?$&'C'/DXRSFQSJQ=G*6/<U3$6;LXVZ=E&'4X+^)<SE$^SILBSMAN?<%@
MN-=#=L:6;/J<S62M#38(W'P>##]A*+Y2,-S@J\"/MM&2YPNQ]_&F0>AV,+T:
M_($Q^5+!<),O;X"7<VJ1V:'W_3#X*6\?O)V'N.^VR^P&D;J4/2 KKL@33]>"
MO Z.[%L!LH("X?(<0_=&'^*^W)RF#0(V33&2G7<XN!6WS](&H<8L#;VIA[BI
ME\9;^OK#4NZ8\6@K5)1H9QS7T,HW^[P=1>E1+[#UJAS;)O&]I8<_Q=)#;^GA
MC[#T!I&7()>NOG%1+JV8B)THPT9:N+P=];H(<ZM;Q3MZ^+V.WB!@;Y4'#,4[
M>OBC'+U!:/^]TMUY/6U?]7_@MA/4)!5S4 J.3B$55?'VO+@P<N7>6,^D,3)S
M'Y>"0SMK!\#O<RG-RX5]"5[]'\;E/U!+ P04    " "TF(U3GZ ;\+$"  #B
M#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S
M85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2
MNMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[
M=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2Q
MQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>X
MU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_P
MZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8Q
MA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R
M]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.
MRW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV0
M3NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_
MAOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X
M87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%
MZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[
MC>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS
M/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "T
MF(U3EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0
M(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I
M6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE
M/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6
MFD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#
M!!0    ( +28C5,<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+
M;L) #/R5U7Y $U"+5$2XE#Z0JA:5BON2=8C%/B*O RU?7R=15*1>>O)Z;(UG
M9A?G2,=]C$?UY5U(A:Z9FWF6I;(&;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y
M/LN\P:"7BY%K0]EU$QE*QA@$[( =PCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;
MZ%RK5,?S2R2\Q,#&;4N*SA5Z,@QV0(SE'WC;B?PT^]0C;/8?1H04>I8+8864
MN-_H^8UH/($L#UW+\0D= ZT,PS/%ML%PZ&C$179EH\]AK$.(<_I/C+&JL(15
M+%L/@8<<"5PG,*0:FZ15,!X*/:XH$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:
MHPQH;0?AHUH+%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\
M 5!+ P04    " "TF(U3)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<O
MA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9
MA@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD
M3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,
M<'AT_@%02P,$%     @ M)B-4V60>9(9 0  SP,  !,   !;0V]N=&5N=%]4
M>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.
MVDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B
M2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*
M$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:
MP'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$Y
ML01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;
MSO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "TF(U3!T%-8H$   "Q
M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( +28C5,XOI*#[P   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( +28C5.97)PC$ 8  )PG   3
M      "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ M)B-
M4RT<2G>(!0  SQ@  !@              ("!#@@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( +28C5.?H!OPL0(  .(,   -
M      "  <P-  !X;"]S='EL97,N>&UL4$L! A0#%     @ M)B-4Y>*NQS
M    $P(   L              ( !J!   %]R96QS+RYR96QS4$L! A0#%
M  @ M)B-4QPX9>H_ 0  / (   \              ( !D1$  'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( +28C5,D'INBK0   /@!   :
M  "  ?T2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M +28C5-ED'F2&0$  ,\#   3              "  >(3  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  "P5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d266949d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d266949d8k.htm">d266949d8k.htm</File>
    <File>d266949dex991.htm</File>
    <File>hyac-20211213.xsd</File>
    <File>hyac-20211213_def.xml</File>
    <File>hyac-20211213_lab.xml</File>
    <File>hyac-20211213_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d266949d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "hyac-20211213_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "d266949d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hyac-20211213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hyac-20211213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hyac-20211213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 32,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "hyac",
   "nsuri": "http://haymaker.com/20211213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d266949d8k.htm",
      "contextRef": "duration_2021-12-13_to_2021-12-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d266949d8k.htm",
      "contextRef": "duration_2021-12-13_to_2021-12-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "hyac_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://haymaker.com/20211213",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "hyac_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://haymaker.com/20211213",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "hyac_UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units Each Consisting Of One Share Of Class A Common Stock And One Fourth Of One Redeemable Warrant [Member]",
        "terseLabel": "Units Each Consisting Of One Share Of Class A Common Stock And One Fourth Of One Redeemable Warrant [Member]"
       }
      }
     },
     "localname": "UnitsEachConsistingOfOneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember",
     "nsuri": "http://haymaker.com/20211213",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "hyac_WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock For 11.50 Per Share [Member]",
        "terseLabel": "Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock For 11.50 Per Share [Member]"
       }
      }
     },
     "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockFor11.50PerShareMember",
     "nsuri": "http://haymaker.com/20211213",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://haymaker.com//20211213/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-21-355703-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-355703-xbrl.zip
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M4 D3U]"2Q?1:>$]ZZQ7"&;E%1]I;NJUF8#H=^G)+SI*>A_XG=!][?#X'B$0
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MO-_.ISDK7#5Q U>P^L2>[EBZ0L-+,=V#*0M,Z4AE?O3)E$XJ6+PNJL#0<RC
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M4F1:%+# (J;U]-K5?4L22>:^AHVOH2A]28-:.G;H@&1!]B\9AK"<BG>G(1H
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M>#VPB3LPD]-4?B'WZL;D4SLMJ#*Y352\B51&]*L5^@$MC=-/(D-$4+_HI2\
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MK[^O MI[:TW+KR;X'U%I26''-&I$H:4?%]1&WS>C9#F_^<M4ON(\R6WQZT#
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MA0\^@[@B;WS^XA?Z\/7EVS=/_PM02P,$%     @ M)B-4X@%C(AJ!   +A(
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M.MXOM81SIU-7YH/"O0^ ]">8FP\-U<7_4$L#!!0    ( +28C5-\1.V,O @
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M6EQQ+Y?DRGP53?_7!+GF_U!+ P04    " "TF(U3E86,0 <&   !/P  %0
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M034AE]C;2[A$C,'['RPR??!V$J8"OM=O;J_VZ'_Z/62UY5]02P$"% ,4
M" "TF(U3L&YZ4](<  #,H@  #@              @ $     9#(V-CDT.60X
M:RYH=&U02P$"% ,4    " "TF(U3ASHNIF\M   ZD@  $0
M@ '^'   9#(V-CDT.61E>#DY,2YH=&U02P$"% ,4    " "TF(U3B 6,B&H$
M   N$@  $0              @ &<2@  :'EA8RTR,#(Q,3(Q,RYX<V102P$"
M% ,4    " "TF(U3WC $A4L&  "T.@  %0              @ $U3P  :'EA
M8RTR,#(Q,3(Q,U]D968N>&UL4$L! A0#%     @ M)B-4WQ$[8R\"   =V,
M !4              ( !LU4  &AY86,M,C R,3$R,3-?;&%B+GAM;%!+ 0(4
M Q0    ( +28C5.5A8Q !P8   $_   5              "  :)>  !H>6%C
G+3(P,C$Q,C$S7W!R92YX;6Q02P4&      8 !@"# 0  W&0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
